NYSE:CNMDMedical Equipment
CONMED Refocuses Portfolio As Gastroenterology Exit And Interim CFO Shift Unfold
CONMED (NYSE:CNMD) has exited the gastroenterology market and transferred global distribution rights for certain product lines to Micro-Tech Endoscopy.
The company has also appointed Andrew Moller as Interim Chief Financial Officer.
For investors watching NYSE:CNMD, these moves come at a time when the share price is around $36.8 and multi year returns have been weak, with the stock down 37.1% over 1 year, 60.8% over 3 years, and 69.5% over 5 years. Stepping away from gastroenterology...

